Literature DB >> 21251361

[Effect of bone marrow mesenchymal stem cells engraftment on secretion of inflammatory cytokine in the early stages of smoke inhalation injury in rabbits].

Wen Chen1, Feng Zhu, Guang-hua Guo, Jian-hua Zhan.   

Abstract

OBJECTIVE: To explore the effect of bone marrow mesenchymal stem cells (MSCs) engraftment on secretion of tumor necrosis factor-α (TNF-α), interleukins (IL-1β, IL-6, IL-10) in peripheral blood and lung homogenates in the early stages of smoke inhalation injury.
METHODS: MSCs were proliferated by the method of whole marrow culture and identified by flow cytometry. Fifty-six healthy New Zealand rabbits were randomly divided into control group (C group, n=8), smoke inhalation injury group (S group, n=24) and smoke inhalation injury+MSCs engraftment group (M group, n=24). The latter two groups were subdivided into 2, 4, 6 hours after injury subgroups, with 8 rabbits in each group. The levels of TNF-α, IL-1β, IL-6 and IL-10 in peripheral blood and lung homogenates were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Compared with C group, concent of pro-inflammatory and anti-inflammatory cytokines in peripheral blood at each time point in S group were increased significantly. The concent of pro-inflammatory cytokines in lung homogenate at each time point in S group was significantly higher than those in C group, and that of anti-inflammatory cytokines showed no significant changes. Compared with the S group, concent of pro-inflammatory cytokines in peripheral blood in M group was decreased significantly, and that of anti-inflammatory cytokines was increased significantly [6 hours TNF-α (μg/L): 1.7±1.7 vs. 4.1±1.6, IL-1β (ng/L): 9.9±1.7 vs. 21.2±2.6, IL-6 (μg/L): 1.0±0.3 vs. 1.3±0.2, IL-10 (ng/L): 15.2±4.4 vs. 7.9±3.5, all P<0.05]. Concent of pro-inflammatory cytokines at each time point in M group was decreased significantly when compared with S group in lung homogenate, while only anti-inflammatory cytokine at 4 hours and 6 hours was increased significantly [6 hours TNF-α (ng/L): 503.0±156.4 vs. 587.7±171.2, IL-1β (ng/L): 0.4±0.2 vs. 0.6±0.2, IL-6 (ng/L): 155.2±13.7 vs. 350.2±20.3, IL-10 (ng/L): 23.3±5.4 vs. 11.0±5.6, all P<0.05].
CONCLUSION: MSCs engraftment could decrease pro-inflammatory cytokines and increase anti-inflammatory cytokines in the early stages of smoke inhalation injury, thus ameliorates inflammatory response, which confers protective effect on smoke inhalation injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251361

Source DB:  PubMed          Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue        ISSN: 1003-0603


  4 in total

1.  Treatment evaluation of Wharton's jelly-derived mesenchymal stem cells using a chronic salpingitis model: an animal experiment.

Authors:  Zhe Li; Zhao Zhang; Xin Chen; Juan Zhou; Xiao-Min Xiao
Journal:  Stem Cell Res Ther       Date:  2017-10-17       Impact factor: 6.832

Review 2.  Preclinical and clinical studies of smoke-inhalation-induced acute lung injury: update on both pathogenesis and innovative therapy.

Authors:  Bingxin Guo; Yichun Bai; Yana Ma; Cong Liu; Song Wang; Runzhen Zhao; Jiaxing Dong; Hong-Long Ji
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 3.  Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.

Authors:  Lauralyn A McIntyre; David Moher; Dean A Fergusson; Katrina J Sullivan; Shirley H J Mei; Manoj Lalu; John Marshall; Malcolm Mcleod; Gilly Griffin; Jeremy Grimshaw; Alexis Turgeon; Marc T Avey; Michael A Rudnicki; Mazen Jazi; Jason Fishman; Duncan J Stewart
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

Review 4.  Emerging therapies for smoke inhalation injury: a review.

Authors:  Alexandra Mercel; Nick D Tsihlis; Rob Maile; Melina R Kibbe
Journal:  J Transl Med       Date:  2020-03-30       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.